drugset / Trial / NCT03005899

Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain

NCT03005899

Phase 3 Terminated 49 enrolled SymBio Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 3 clinical trial to compare the safety and efficacy of SyB P-1501 with the SyB P-1501 placebo for the management of the first 24 hours of post-operative pain.

Timeline

Start
2016-11-21
Primary completion
2017-07-21
Completion
2017-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 40 ug Other

Indications

No indication recorded.